Parsons Capital Management’s iShares Biotechnology ETF IBB Stock Holding History

Parsons Capital Management’s Portfolio IBB Stock Details IBB Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$212K	Sell	1,115 -13,501	-92%	-$2.32M	0.01%	508
2026 Q1	$2.47M	Buy	+14,616	New	+$2.5M	0.11%	166
2025 Q2	–	Sell	-6,375	Closed	-$815K	–	442
2025 Q1	$815K	Hold	6,375	–	–	0.04%	274
2024 Q4	$843K	Buy	+6,375	New	+$896K	0.05%	262
2020 Q3	–	Sell	-2,875	Closed	-$393K	–	352
2020 Q2	$393K	Buy	+2,875	New	+$366K	0.04%	251
2018 Q1	–	Sell	-2,265	Closed	-$242K	–	360
2017 Q4	$242K	Sell	2,265 -105	-4%	-$11.2K	0.03%	337
2017 Q3	$264K	Buy	+2,370	New	+$253K	0.03%	320
2015 Q2	–	Sell	-585	Closed	-$67K	–	419
2015 Q1	$67K	Buy	+585	New	+$64.5K	0.01%	433

Other funds holding IBB

Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return

Citigroup New York $303B AUM 53.02% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

BNP Paribas Financial Markets Paris, France $289B AUM 60.46% 1-Year Est. Return

Two Sigma Investments New York $138B AUM 41.87% 1-Year Est. Return

Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return

Envestnet Asset Management Chicago, Illinois $424B AUM 22.9% 1-Year Est. Return

Raymond James Financial St Petersburg, Florida $369B AUM 28.27% 1-Year Est. Return

Wells Fargo San Francisco, California $617B AUM 30.33% 1-Year Est. Return

Commerce Bank Kansas City, Missouri $22.8B AUM 28.56% 1-Year Est. Return

Parsons Capital Management's IBB Position: Q2 2026 in Review

Parsons Capital Management reduced its iShares Biotechnology ETF (IBB) stake by 92% in Q2 2026, selling an estimated $2.32M and leaving 1,115 shares worth $212K. The position accounts for 0.01% of the portfolio, ranked #508.

Parsons Capital Management first reported a position in IBB in Q1 2015 and has held it in 8 quarters since. The position peaked at $2.47M in Q1 2026. 960 funds tracked by Wall St. Rank hold IBB as of Q2 2026.

Parsons Capital Management held 1,115 shares of iShares Biotechnology ETF worth $212K as of Q2 2026.
Parsons Capital Management sold 13,501 iShares Biotechnology ETF shares in Q2 2026, an estimated $2.32M.
iShares Biotechnology ETF made up 0.01% of Parsons Capital Management's portfolio in Q2 2026, its #508 holding.
Parsons Capital Management first reported a position in iShares Biotechnology ETF in Q1 2015 and has held it in 8 quarters since.
Parsons Capital Management's iShares Biotechnology ETF position peaked at $2.47M in Q1 2026.
960 funds tracked by Wall St. Rank held iShares Biotechnology ETF as of Q2 2026.

Based on Parsons Capital Management's 13F filing for Q2 2026, filed 24 Jul 2026.